Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
European Journal of Haematology
|
March 24, 2009
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma
Edward A Stadtmauer, Donna M Weber, Ruben Niesvizky, et al.
Biophysical Journal
|
June 4, 2021
Myofiber stretch induces tensile and shear deformation of muscle stem cells in their native niche
Mohammad Haroon, Jenneke Klein-Nulend, Astrid D Bakker, et al.
Clinical Lymphoma & Myeloma
|
May 2, 2009
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results
Antonio Palumbo, Patrizia Falco, Antonietta Falcone, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Open Raman Microscopy (ORM): A Modular Hardware and Software Framework for Accessible Raman Imaging
Kevin T Uning, Henry Brisebois, Conor C Horgan, et al.
The New England Journal of Medicine
|
November 23, 2007
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Meletios Dimopoulos, Andrew Spencer, Michael Attal, et al.
The New England Journal of Medicine
|
November 23, 2007
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Donna M Weber, Christine Chen, Ruben Niesvizky, et al.
British Journal of Haematology
|
June 24, 2009
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
Christine Chen, Donna E Reece, David Siegel, et al.
Nature Communications
|
April 14, 2026
Restorative macrophage-derived RNAseT2 stimulates muscle stem cell fusion via an SLK/N-WASP/actin bundling dependent axis
Michéle Weiss-Gayet, Gaëtan Juban, Emmeran Le Moal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2017
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
Philip L McCarthy, Sarah A Holstein, Maria Teresa Petrucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2008
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia
Leslie A Andritsos, Amy J Johnson, Gerard Lozanski, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
European Journal of Haematology
|
March 24, 2009
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma
Edward A Stadtmauer, Donna M Weber, Ruben Niesvizky, et al.
Biophysical Journal
|
June 4, 2021
Myofiber stretch induces tensile and shear deformation of muscle stem cells in their native niche
Mohammad Haroon, Jenneke Klein-Nulend, Astrid D Bakker, et al.
Clinical Lymphoma & Myeloma
|
May 2, 2009
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results
Antonio Palumbo, Patrizia Falco, Antonietta Falcone, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Open Raman Microscopy (ORM): A Modular Hardware and Software Framework for Accessible Raman Imaging
Kevin T Uning, Henry Brisebois, Conor C Horgan, et al.
The New England Journal of Medicine
|
November 23, 2007
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
Meletios Dimopoulos, Andrew Spencer, Michael Attal, et al.
The New England Journal of Medicine
|
November 23, 2007
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Donna M Weber, Christine Chen, Ruben Niesvizky, et al.
British Journal of Haematology
|
June 24, 2009
Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
Christine Chen, Donna E Reece, David Siegel, et al.
Nature Communications
|
April 14, 2026
Restorative macrophage-derived RNAseT2 stimulates muscle stem cell fusion via an SLK/N-WASP/actin bundling dependent axis
Michéle Weiss-Gayet, Gaëtan Juban, Emmeran Le Moal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 26, 2017
Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis
Philip L McCarthy, Sarah A Holstein, Maria Teresa Petrucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 23, 2008
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia
Leslie A Andritsos, Amy J Johnson, Gerard Lozanski, et al.
Page
of 5